Description

Description

Sita-Met XR 50/1000mg Tablet is a high-strength, extended-release combination medicine intended for adults with type 2 diabetes mellitus who require a larger Metformin dose alongside Sitagliptin, delivered through a controlled-release system rather than an immediate-release format. This tablet is generally considered for patients who have already tolerated lower extended-release strengths well and need a stronger glucose-lowering effect, or for those switching from an immediate-release combination who would benefit from smoother, once-daily dosing at the higher Metformin level. The extended-release matrix allows the medicine to be absorbed gradually over several hours, aiming to reduce the peaks and troughs in drug levels that can occur with immediate-release tablets while easing the digestive burden often associated with a high Metformin dose. The pack contains 14 tablets, typically supporting a two-week course as determined by the prescribing physician, and this medicine should only be introduced or adjusted under close medical supervision.

Ingredients

Each Sita-Met XR 50/1000mg Tablet contains Sitagliptin 50mg together with Metformin Hydrochloride 1000mg formulated in an extended-release matrix. Sitagliptin prolongs the action of the body’s incretin hormones to support appropriate insulin release after meals, while the high-dose extended-release Metformin component is embedded in a controlled-release polymer system, typically involving hydroxypropyl methylcellulose, that regulates how gradually the medicine dissolves and enters the bloodstream. Other inactive ingredients commonly include microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, and a protective film coat that supports the tablet’s structure and appearance.

Dosage Form

This medicine is manufactured as a large, film-coated extended-release oral tablet, built around a controlled-release matrix engineered to accommodate the higher Metformin dose while still permitting gradual absorption over an extended period. The tablets are supplied in blister strips designed to protect them from moisture and light, helping maintain the integrity of the release mechanism until the expiry date printed on the pack.

Uses

Sita-Met XR 50/1000mg Tablet is used to manage blood sugar levels in adults with type 2 diabetes mellitus who need the combined benefit of Sitagliptin’s incretin-based action and a high, steadily released dose of Metformin. It is often prescribed for patients progressing through a structured dose-titration plan, where the Metformin component is gradually increased to reach an effective glucose-lowering dose while minimizing digestive side effects through the extended-release delivery system. The Sitagliptin portion supports insulin secretion in response to food intake and reduces unnecessary hepatic glucose output, while the high-dose extended-release Metformin further lowers liver glucose production and enhances the body’s sensitivity to insulin over a sustained period. This tablet is generally used as part of a broader diabetes care plan involving dietary management, regular exercise, and consistent monitoring to support long-term blood sugar control.

How to Use

Sita-Met XR 50/1000mg Tablet should be taken exactly as directed by the prescribing doctor, usually once daily with the evening meal to support consistent absorption throughout the following hours. The tablet must always be swallowed whole with an adequate amount of water and should never be crushed, broken, or chewed, as this could disrupt the extended-release mechanism and cause the full Metformin dose to be released too rapidly, increasing the likelihood of digestive side effects. Given the higher strength, doctors typically introduce this tablet gradually after confirming tolerance to lower extended-release doses. Patients may occasionally notice a tablet-like residue in their stool, which is simply the depleted shell of the release matrix and is considered a normal and harmless occurrence. Doses should never be doubled to make up for a missed one; instead, the missed dose should be taken as soon as remembered unless the next dose is nearly due.

Side Effects

While the extended-release format is designed to improve digestive tolerability, the higher Metformin content in this strength means gastrointestinal effects such as nausea, bloating, diarrhea, or a metallic taste may still occur, particularly during the initial period of treatment or shortly after a dose increase. Effects linked to the Sitagliptin component may include headache, sore throat, or symptoms resembling an upper respiratory infection. Some patients may also experience a temporary reduction in appetite. In rare but serious situations, symptoms suggestive of lactic acidosis (such as unusual muscle pain, rapid or labored breathing, or unexplained exhaustion), pancreatitis, or allergic reactions like rash and swelling may develop and require immediate medical attention. Any severe or persistent symptoms should be reported to a doctor without delay.

Pregnancy & Breastfeeding

The use of Sita-Met XR 50/1000mg Tablet during pregnancy is generally avoided unless a physician determines that the treatment benefit clearly outweighs the potential risk, since blood sugar management in pregnancy is usually approached through alternative treatment protocols better suited to that stage. Women who are pregnant, planning a pregnancy, or currently breastfeeding should discuss their diabetes care plan with their doctor before starting or continuing this medicine, allowing safer alternatives to be considered if needed. As both active ingredients may pass into breast milk to some degree, breastfeeding mothers should seek specific medical guidance before use.

Storage Instructions

Store Sita-Met XR 50/1000mg Tablets in a cool, dry place away from direct sunlight, excess heat, and humidity, ideally at a temperature below 30°C. Keep the tablets in their original blister packaging until they are ready to be used, in order to protect the extended-release coating, and store them securely out of the reach and sight of children and pets. Avoid keeping the medicine in bathrooms or other damp areas, and never allow the tablets to freeze. Always check the expiry date before use, and dispose of any expired or unused tablets responsibly through an appropriate medicine take-back program rather than household waste or drains.

FAQS

Q1. Why would a doctor prescribe the 1000mg XR strength instead of 500mg XR?
This higher strength is generally reserved for patients who need a stronger glucose-lowering effect and have already shown good tolerance to lower extended-release doses.

Q2. Does the extended-release format reduce stomach side effects even at this higher dose?
Many patients find extended-release Metformin gentler on digestion than immediate-release versions, but some gastrointestinal effects may still occur, especially at higher doses.

Q3. Can this tablet be split in half to make it easier to swallow?
No, splitting or crushing this tablet can disrupt its controlled-release mechanism and should be avoided unless specifically instructed by a doctor.

Q4. Is this strength suitable as a starting dose for newly diagnosed diabetes?
It is typically not used as a starting dose; doctors usually titrate patients up to this strength gradually after assessing tolerance at lower doses.

Q5. How often should kidney function be checked while on this medicine?
Given the higher Metformin dose, doctors generally recommend regular kidney function monitoring, with frequency tailored to the individual patient’s health status.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.